Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling immune responses to autologous and allogeneic human stem cell-derived islet grafts in vivo.

JCI insight·2026
Same author

Wireless battery-free oxygenation devices enable extended immunosuppression-free islet transplantation in minimally invasive sites.

Device·2026
Same author

Optimizing post-transplantation detection of subcutaneously transplanted islets using dithizone staining.

BMC methods·2026
Same author

Divergent cell-type specific hypoxia responses in human stem cell-derived and primary islets.

Scientific reports·2026
Same author

A digital twin of pancreatic islet differentiation predicts cell fate.

bioRxiv : the preprint server for biology·2026
Same author

Depolymerizing F-actin accelerates the exit from pluripotency to enhance stem cell-derived islet differentiation.

Nature communications·2026

Related Experiment Video

Updated: Jun 20, 2026

Microinjection-based System for In Vivo Implantation of Embryonic Cardiomyocytes in the Avian Embryo
08:52

Microinjection-based System for In Vivo Implantation of Embryonic Cardiomyocytes in the Avian Embryo

Published on: February 17, 2019

Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes.

Renita E Horton1, Jeffrey R Millman, Clark K Colton

  • 1Harvard University School of Engineering & Applied Sciences, 29 Oxford Street, Pierce Hall Room 317, Cambridge, MA 02138, USA.

Regenerative Medicine
|September 19, 2009
PubMed
Summary
This summary is machine-generated.

Engineering the stem cell microenvironment, using components like the extracellular matrix and bioreactors, can improve the efficiency of generating cardiomyocytes (heart cells) for cell replacement therapies.

More Related Videos

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells
06:28

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells

Published on: September 25, 2016

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Related Experiment Videos

Last Updated: Jun 20, 2026

Microinjection-based System for In Vivo Implantation of Embryonic Cardiomyocytes in the Avian Embryo
08:52

Microinjection-based System for In Vivo Implantation of Embryonic Cardiomyocytes in the Avian Embryo

Published on: February 17, 2019

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells
06:28

Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells

Published on: September 25, 2016

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Area of Science:

  • Stem Cell Biology
  • Cardiovascular Research
  • Tissue Engineering

Background:

  • Embryonic stem cells and induced pluripotent stem cells offer a renewable source for cardiomyocytes in myocardial repair.
  • Current differentiation methods yield insufficient cell numbers and low efficiency for therapeutic use.

Purpose of the Study:

  • To explore methods for enhancing cardiomyocyte differentiation by engineering the stem cell microenvironment.
  • To address challenges in large-scale production and therapeutic application of stem cell-derived cardiomyocytes.

Main Methods:

  • Utilizing extracellular matrix components to provide mechanical cues and direct stem cell differentiation.
  • Employing bioreactors to control the cellular microenvironment and scale up cell production.
  • Investigating strategies to improve cell engraftment into damaged cardiac tissue.

Main Results:

  • Engineering the stem cell microenvironment shows promise in improving cardiomyocyte differentiation efficiency.
  • Extracellular matrix and bioreactors are key tools for controlled stem cell differentiation.
  • Further research is needed to optimize purification, cardiac function assessment, and safety.

Conclusions:

  • Controlled manipulation of the stem cell microenvironment is crucial for efficient cardiomyocyte generation.
  • Bioreactors and extracellular matrix components are essential for scalable production of cardiomyocytes.
  • Addressing large-scale differentiation, purification, functional assessment, and safety is vital for clinical translation.